Login
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd

brbiotech.com

Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.

Financial Snapshot

Revenue
TTM
$514.4M
Gross Margin
TTM
74.54%
Net Income
TTM
-$59.32M
Current Assets
2026 Q1
$701.0M
Current Liabilities
2026 Q1
$229.8M
Current Ratio
2026 Q1
305.02%
Total Assets
2026 Q1
$787.8M
Total Liabilities
2026 Q1
$271.3M
Book Value
2026 Q1
516.5M
Cash
2026 Q1
$446.0M
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $109.81 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support